Testing magnesium in dialysis fluid for people in OMAGOD study
Part of Blood & lymphatic, Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is for people already enrolled in the OMAGOD pilot study. It tests whether changing the amount of magnesium in a special dialysis fluid can reduce unwanted blood clotting and inflammation during dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be taking part in the OMAGOD pilot trial.
- You cannot join if you are not part of that pilot trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different types of dialysis fluid affect calcium buildup in the blood vessels of people with kidney disease on hemodialysis. It may help improve heart health for dialysis patients.
This trial studies whether giving magnesium helps people who are hospitalized with low magnesium levels. It may help correct low magnesium and improve how patients feel and recover.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This trial looks at magnesium levels in people with inflammatory bowel disease, an ileostomy, or bile acid diarrhea, compared to healthy volunteers. It aims to understand how these conditions affect magnesium in the body.
This study tests whether changing the salt (sodium) level in dialysis fluid can reduce problems in blood vessels. It is done in adult dialysis centers to compare outcomes between two sodium levels.
This study tests a special type of dialysis fluid with a higher amount of a mineral buffer (bicarbonate) to see if it helps keep minerals more balanced in your blood. It may improve how your body handles calcium and other minerals during dialysis.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.